loading

Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Forecast

The Virtus Lifesci Biotech Clinical Trials Etf (BBC) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $30.13, representing a +96.65% increase from the current price of $15.32. The highest analyst price target is $34.44, and the lowest is $25.81.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BBC Price Target
Average 43.60 (+184.61% Upside)
loading

Is Virtus Lifesci Biotech Clinical Trials Etf (BBC) A Buy Now?

Oscillators
Name Value Action
RSI(14) 25.82 Buy
STOCH(9,6) 7.7518 Buy
STOCHRSI(14) 18.47 Buy
MACD(12,26) -1.1798 Sell
ADX(14) 39.88 Sell
William %R -97.80 Buy
CCI(14) -184.36 Sell
Buy: 4 Sell: 3 Neutral: 0
Summary: Buy
Moving Averages
Period Simple Exponential
MA10
17.89
Sell
17.50
Sell
MA20
18.86
Sell
18.50
Sell
MA50
20.58
Sell
20.31
Sell
MA100
23.06
Sell
22.29
Sell
MA200
25.43
Sell
24.06
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, BBC could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 13 signaling Sell signals and 0 Neutral signals. This might not be a good time to consider opening new positions on BBC, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 25.82 indicates that BBC is oversold. This indicates that BBC price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
  2. STOCH (Stochastic Oscillator): The STOCH value of 7.7518 indicates that BBC is oversold. This indicates that BBC price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 18.47 indicates that BBC is oversold. This suggests that BBC price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 39.88 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -184.36 indicates that BBC is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term BBC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Virtus Lifesci Biotech Clinical Trials Etf financial reports and earnings history, Virtus Lifesci Biotech Clinical Trials Etf (BBC) stock could reach $25.98 by 2030, $20.35 by 2040 and $23.28 by 2050. See the projected annual prices until 2050 of the Virtus Lifesci Biotech Clinical Trials Etf stock below:

  • Virtus Lifesci Biotech Clinical Trials Etf (BBC) is expected to reach an average price of $16.84 in 2035, with a high prediction of $17.19 and a low estimate of $14.56. This indicates an $9.95% rise from the last recorded price of $15.32.
  • Virtus Lifesci Biotech Clinical Trials Etf (BBC) stock is projected to chart a bullish course in 2040, with an average price target of $19.47, representing an $27.07% surge from its current level. The forecast ranges from a conservative $17.65 to a sky-high $20.35.
  • Our analysts predict Virtus Lifesci Biotech Clinical Trials Etf (BBC) to jump 30.64% by 2045, soaring from $18.01 to an average price of $20.01, potentially reaching $22.64. While $18.01 is the low estimate, the potential upside is significant.
  • Virtus Lifesci Biotech Clinical Trials Etf (BBC) stock is expected to climb by 2050, reaching an average of $23.22, a $51.55% jump from its current level. However, a wide range of estimates exists, with high and low targets of $23.28 and $19.30, respectively, highlighting the market's uncertainty.

Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Year by Year Forecast

Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Price Forecast for 2025

Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) is expected to reach an average price of $33.14 in 2025, with a high prediction of $44.48 and a low estimate of $21.79. This indicates an +116.31% rise from the last recorded price of $15.32.
Month Average Low High Change from today's price
May, 2025 $33.30 $25.81 $34.44 +117.33%
June, 2025 $39.70 $31.85 $41.78 +159.11%
July, 2025 $42.49 $37.42 $42.92 +177.33%
August, 2025 $41.38 $40.77 $44.48 +170.09%
September, 2025 $40.05 $37.14 $43.45 +161.41%
October, 2025 $36.35 $34.46 $40.99 +137.27%
November, 2025 $37.77 $35.18 $41.42 +146.55%
December, 2025 $37.46 $37.28 $42.64 +144.51%

Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Price Forecast for 2026

The predicted value for Virtus Lifesci Biotech Clinical Trials Etf (BBC) in 2026 is set at an average of $49.35. Estimates vary from a peak of $61.39 to a trough of $37.31, indicating an +222.13% surge from the present price of $15.32.
Month Average Low High Change from today's price
January, 2026 $45.21 $37.31 $45.24 +195.11%
February, 2026 $50.62 $44.25 $51.75 +230.43%
March, 2026 $53.19 $47.96 $53.29 +247.21%
April, 2026 $57.82 $50.00 $61.39 +277.44%
May, 2026 $54.50 $47.46 $58.15 +255.75%
June, 2026 $47.61 $46.60 $55.50 +210.74%
July, 2026 $44.93 $42.90 $51.21 +193.25%
August, 2026 $49.88 $44.73 $49.88 +225.57%
September, 2026 $48.37 $45.97 $50.98 +215.72%
October, 2026 $44.69 $42.62 $47.99 +191.70%
November, 2026 $46.42 $41.22 $46.73 +203.00%
December, 2026 $44.48 $44.37 $47.93 +190.35%

Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Virtus Lifesci Biotech Clinical Trials Etf (BBC) is $31.73, with a high forecast of $46.89 and a low forecast of $16.58. This indicates an +107.15% increase from the last price of $15.32.
Month Average Low High Change from today's price
January, 2027 $42.88 $42.34 $45.02 +179.90%
February, 2027 $41.90 $41.90 $46.89 +173.51%
March, 2027 $38.40 $35.53 $41.81 +150.67%
April, 2027 $31.86 $30.25 $39.63 +107.96%
May, 2027 $27.48 $25.69 $31.21 +79.38%
June, 2027 $25.13 $24.54 $30.48 +64.00%
July, 2027 $26.75 $24.08 $28.14 +74.60%
August, 2027 $22.62 $22.48 $29.04 +47.62%
September, 2027 $18.53 $16.60 $23.27 +20.93%
October, 2027 $18.61 $16.58 $20.49 +21.46%
November, 2027 $24.14 $19.02 $24.16 +57.56%
December, 2027 $27.44 $21.86 $27.50 +79.11%

Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Price Forecast for 2028

In 2028, Virtus Lifesci Biotech Clinical Trials Etf (BBC) is projected to reach an average price of $23.89, with a high projection of $27.89 and a low estimate of $19.90. This indicates an +55.96% rise from the last price of $15.32.
Month Average Low High Change from today's price
January, 2028 $24.40 $23.68 $27.89 +59.25%
February, 2028 $23.39 $21.58 $26.21 +52.67%
March, 2028 $24.69 $22.50 $25.04 +61.14%
April, 2028 $23.69 $22.46 $25.66 +54.67%
May, 2028 $23.53 $22.34 $24.84 +53.58%
June, 2028 $25.79 $21.97 $26.51 +68.35%
July, 2028 $25.39 $25.39 $27.55 +65.70%
August, 2028 $21.43 $20.81 $25.51 +39.86%
September, 2028 $20.55 $19.90 $22.45 +34.14%
October, 2028 $23.74 $20.07 $23.78 +54.97%
November, 2028 $23.81 $22.59 $24.29 +55.42%
December, 2028 $22.78 $22.32 $25.34 +48.69%

Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Price Forecast for 2029

The 2029 price forecast for Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) is $23.26 on average, with a high prediction of $30.82 and a low estimate of $15.70. This represents an +51.82% increase from the previous price of $15.32.
Month Average Low High Change from today's price
January, 2029 $22.90 $21.65 $23.76 +49.50%
February, 2029 $20.34 $19.81 $22.68 +32.75%
March, 2029 $19.85 $19.85 $20.78 +29.56%
April, 2029 $17.34 $16.95 $19.56 +13.18%
May, 2029 $16.18 $15.70 $18.26 +5.60%
June, 2029 $19.02 $15.73 $19.02 +24.15%
July, 2029 $23.28 $19.00 $23.99 +51.94%
August, 2029 $24.21 $22.48 $25.02 +58.02%
September, 2029 $27.28 $24.05 $27.55 +78.09%
October, 2029 $27.57 $26.86 $30.82 +79.96%
November, 2029 $23.70 $23.40 $28.11 +54.73%
December, 2029 $25.87 $23.34 $26.59 +68.87%

Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Price Forecast for 2030

Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) is expected to reach an average price of $29.16 in 2030, with a high forecast of $37.75 and a low forecast of $20.56. This signifies an +90.32% surge from the last price of $15.32.
Month Average Low High Change from today's price
January, 2030 $24.34 $23.83 $25.98 +58.89%
February, 2030 $26.08 $24.24 $27.02 +70.26%
March, 2030 $24.14 $24.14 $26.14 +57.54%
April, 2030 $24.05 $23.28 $25.01 +56.96%
May, 2030 $21.61 $21.42 $25.62 +41.06%
June, 2030 $23.59 $20.56 $23.59 +53.98%
July, 2030 $27.02 $23.50 $27.05 +76.38%
August, 2030 $35.31 $27.16 $35.35 +130.47%
September, 2030 $34.84 $32.16 $37.75 +127.45%
October, 2030 $35.60 $32.61 $36.36 +132.35%
November, 2030 $24.15 $22.10 $36.21 +57.62%
December, 2030 $24.85 $20.58 $27.92 +62.24%
exchange_traded_fund VTV
$156.94
price down icon 5.93%
exchange_traded_fund VUG
$334.02
price down icon 6.06%
exchange_traded_fund IJH
$52.88
price down icon 4.87%
exchange_traded_fund EFA
$75.02
price down icon 6.60%
exchange_traded_fund IWF
$325.67
price down icon 6.00%
exchange_traded_fund QQQ
$422.67
price down icon 6.21%
Cap:     |  Volume (24h):